Every material Form 8-K Armada Acquisition Corp. III has filed with the SEC since February 25, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Armada Acquisition Corp. III, a special purpose acquisition company, signed a business combination agreement on October 31, 2026 with Brains Bioceutical Corp., a Vancouver-based maker of cannabinoid active pharmaceutical ingredients and drug developer. The deal values Brains at an implied pre-money equity value of approximately $750.0 million, and the combined company is expected to trade on Nasdaq as BAPI, with closing expected in the second quarter of 2027 subject to shareholder and regulatory approvals.
Enterprise value of $750.0 million, with new PubCo shares priced at a $10.20 reference value per share
14,705,882 additional earnout shares held in escrow, released if PubCo shares reach $12.50 or $15.00 volume-weighted average price over a three-year earnout period
Closing expected in the second quarter of 2027, subject to shareholder votes, Form F-4 registration effectiveness, Nasdaq listing approval and regulatory approvals
Combined company expected to be named Brains Therapeutics Corp. and trade on Nasdaq under the ticker BAPI
Armada Acquisition Corp. III, a blank-check SPAC, said holders of its 24,850,000 units may separate them into Class A ordinary shares and warrants beginning March 27, 2026. The separated shares and warrants will trade on Nasdaq under AACI and AACIW, while unseparated units continue as AACIU; this is an administrative change that does not alter the company's terms or the warrant exercise price.
Units may be separated into shares and warrants starting March 27, 2026
Separated shares trade as AACI and warrants as AACIW on Nasdaq; unseparated units remain AACIU
Each whole warrant entitles the holder to buy one share for $11.50; no fractional warrants will be issued
Initial public offering gross proceeds were $248,500,000 at $10.00 per unit
Armada Acquisition Corp. III, a blank check company, completed its initial public offering on February 19, 2026, selling 24,850,000 units at $10.00 each for gross proceeds of $248.5 million. The full $248.5 million was placed in a U.S.-based trust account, and the filing states the company has not selected a target business, so trust funds stay in the account until a business combination or redemption.
IPO closed February 19, 2026: 24,850,000 units at $10.00 each, including 2,350,000 units from a partial over-allotment exercise.
$248.5 million placed in a trust account maintained by Continental Stock Transfer & Trust Company.
Private placement of 672,000 units at $10.00 each to the sponsor and underwriters, for gross proceeds of $6.72 million.
Sponsor forfeited 345,083 Class B ordinary shares after the partial over-allotment exercise, leaving it with 8,252,834.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Armada Acquisition Corp. III filing is on SEC EDGAR ↗. 8-K briefs of other companies →